We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOWG
3226
Sow Good
SOWG
$63M
| $5.96K | ﹤0.01% |
+1,154
| New | +$11.4K |
|
|
XTLB
3227
XTL Biopharmaceuticals
XTLB
$6.86M
| $5.94K | ﹤0.01% |
+2,560
| New | +$10.4K |
|
3228
XWELL
XWEL
$9.04M
| $5.58K | ﹤0.01% |
+11,975
| New | +$10.1K |
|
|
NAKA
3229
Nakamoto Inc
NAKA
$77.8M
| $5.46K | ﹤0.01% |
+389
| New | +$10.2K |
|
|
VSTD
3230
Vestand Inc
VSTD
| $5.28K | ﹤0.01% |
+23,036
| New | +$16.9K |
|
|
EZRA
3231
Reliance Global Group
EZRA
$1.65M
| $5.28K | ﹤0.01% |
+258
| New | +$8.08K |
|
|
ZYXI
3232
DELISTED
Zynex
ZYXI
| $5.18K | ﹤0.01% |
41,151
+14,740
| +56% | +$15.2K |
|
|
MYND
3233
Mynd.ai
MYND
$19.1M
| $5.1K | ﹤0.01% |
11,679
+121
| +1% | +$78 |
|
3234
Ryde Group
RYDE
$115M
| $4.98K | ﹤0.01% |
19,155
-20,790
| -52% | -$9.61K |
|
|
DKI
3235
DarkIris Inc
DKI
$8.68M
| $4.95K | ﹤0.01% |
+959
| New | +$8.55K |
|
3236
Zhongchao
ZCMD
$1.31M
| $4.92K | ﹤0.01% |
+15
| New | +$7.75K |
|
|
TLIH
3237
Ten-League International
TLIH
$17M
| $4.71K | ﹤0.01% |
+1,274
| New | +$5.47K |
|
|
CRE
3238
Cre8 Enterprise Ltd
CRE
$5.1M
| $4.53K | ﹤0.01% |
+1,636
| New | +$9.2K |
|
3239
CBL International Ltd
BANL
$10.1M
| $4.48K | ﹤0.01% |
774
-514
| -40% | -$3.5K |
|
|
TDIC
3240
Dreamland Ltd
TDIC
$3.68M
| $4.11K | ﹤0.01% |
+177
| New | +$24.1K |
|
3241
AGAPE ATP
ATPC
$2.32M
| $4.1K | ﹤0.01% |
769
+552
| +254% | +$27K |
|
|
FCHL
3242
Fitness Champs Holdings
FCHL
$1.33M
| $4K | ﹤0.01% |
+38
| New | +$6.79K |
|
|
AURE
3243
Aurelion Inc
AURE
$61.8M
| $3.81K | ﹤0.01% |
1,526
-349
| -19% | -$1.8K |
|
|
CANF
3244
Can-Fite BioPharma American Depositary Shares
CANF
$6.9M
| $3.74K | ﹤0.01% |
+934
| New | +$7.32K |
|
|
KIDZ
3245
KIDZ AI Inc Class B
KIDZ
$1.22M
| $3.39K | ﹤0.01% |
38
+6
| +19% | +$1.71K |
|
3246
GEE Group
JOB
$23.1M
| $2.26K | ﹤0.01% |
11,592
-9,009
| -44% | -$1.75K |
|
|
CARM
3247
DELISTED
Carisma Therapeutics
CARM
| $1.72K | ﹤0.01% |
+40,097
| New | +$10K |
|
|
VIVK
3248
Vivakor
VIVK
$1.29M
| $908 | ﹤0.01% |
+23
| New | +$15.3K |
|
|
ENFY
3249
DELISTED
Enlightify Inc
ENFY
| $618 | ﹤0.01% |
+10,844
| New | +$8.59K |
|
|
ILLR
3250
Triller Group Inc
ILLR
$19.8M
| $538 | ﹤0.01% |
+1,680
| New | +$10.4K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.